Home › Funds › Kalehua Capital Management LLC › BETRF
Kalehua Capital Management LLC position in BETRF
BETTERLIFE PHARMA INC
Kalehua Capital Management LLC reported holding 27,710,000 shares of BETRF (BETTERLIFE PHARMA INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 5.04% of its reported portfolio and ranking #9 among its reported holdings. Kalehua Capital Management LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Kalehua Capital Management LLC's BETRF position evolved
Kalehua Capital Management LLC first disclosed a stake in BETRF in Q3 2026 at 27,710,000 shares (US$6.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 27.71M | $6.68M | New |
About BETRF and 13F data
BETRF (BETTERLIFE PHARMA INC) is a company whose sector is not yet classified in our data. 0 other funds we track also report a position in BETRF. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BETRF
No other tracked fund reports a position in BETRF.
More on Kalehua Capital Management LLC
FAQ
How long has Kalehua Capital Management LLC held BETRF?
Kalehua Capital Management LLC has disclosed BETRF holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Kalehua Capital Management LLC's current position in BETRF?
As of Q3 2026, Kalehua Capital Management LLC holds 27.71M shares of BETRF (BETTERLIFE PHARMA INC), valued at $6.68M, representing 5.04% of its reported portfolio and ranking #9.
Has Kalehua Capital Management LLC been buying or selling BETRF?
In the latest 13F filing (Q3 2026), Kalehua Capital Management LLC newly opened its position in BETRF.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.